Robert Markewitz
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Autoimmune Neurological Disorders and Treatments
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 2
-
- Clinical Laboratory Practices and Quality Control 2
- Alzheimer's disease research and treatments 1
- Co-authors
- Klaus‐Peter Wandinger (12 shared papers)Ralf Junker (10 shared papers)Justina Dargvainiene (11 shared papers)Martin Schecklmann (3 shared papers)Berthold Langguth (3 shared papers)Katja Steinhagen (4 shared papers)Frank Leypoldt (7 shared papers)Benjamin Schomburg (4 shared papers)
- Journals
- Scientific Reports (2 papers)New England Journal of Medicine (2 papers)Clinical Microbiology and Infection (2 papers)Journal of Neuroimmunology (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- GermanySpainSwitzerland
In The Last Decade
Robert Markewitz
18 papers receiving 97 citations
Peers
Comparison fields: 5 of 38
- Infectious Diseases 45
- Neurology 16
- Neurology 8
- Cognitive Neuroscience 14
- Animal Science and Zoology 7
Countries citing papers authored by Robert Markewitz
This map shows the geographic impact of Robert Markewitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Markewitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Markewitz more than expected).
Fields of papers citing papers by Robert Markewitz
This network shows the impact of papers produced by Robert Markewitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Markewitz. The network helps show where Robert Markewitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Markewitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 22 | |
| 2 | 2022 | 11 | |
| 3 | 2021 | 8 | |
| 4 | 2022 | 8 | |
| 5 | 2018 | 8 | |
| 6 | 2022 | 7 | |
| 7 | 2017 | 7 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2025 | 0 |
About Robert Markewitz
Robert Markewitz is a scholar working on Infectious Diseases, Physiology, Neurology, Cognitive Neuroscience and Epidemiology, having authored 19 papers that have together received 98 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (2 papers), Clinical Laboratory Practices and Quality Control (2 papers), Neural dynamics and brain function (2 papers), Advanced Memory and Neural Computing (2 papers), Platelet Disorders and Treatments (2 papers), Genetics and Neurodevelopmental Disorders (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Infectious Diseases (45 citations), Neurology (16 citations), Neurology (8 citations), Cognitive Neuroscience (14 citations) and Animal Science and Zoology (7 citations). Robert Markewitz has collaborated with scholars based in Germany, Spain and Switzerland. Frequent co-authors include Klaus‐Peter Wandinger, Ralf Junker, Justina Dargvainiene, Martin Schecklmann, Berthold Langguth, Katja Steinhagen, Frank Leypoldt, Benjamin Schomburg, Jan Rupp and Victor Herbst. Their work appears in journals such as Scientific Reports, New England Journal of Medicine, Clinical Microbiology and Infection, Journal of Neuroimmunology and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.